Sebi said it could monitor cryptocurrencies that take the form of...
Category:
Indian News
Latest
General insurers issue around 700 surety bonds for Rs 3000 crore in recent months
So far, NHAI has received 164 Insurance surety bonds consisting of...
Hinduja group seeks time beyond May 27 to pay Rs 9661 crore for acquiring Reliance Capital Limited
According informed sources, CoC in today’s meeting has taken a...
Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan
Vardhan said the late stage trial generally involves thousands of participants, sometimes 30,000 to 40,000.
Of the vaccines currently in Phase 3 trials, all are administered by injection, according to the World Health Organization (WHO).
India’s passenger vehicles exports fall 58% in first half of FY21
“This can be largely attributed to the COVID-19 related disruptions globally, which has led to closure of plants and dealerships, supply chain disruptions, curfews in cities and interruptions in international trade,” SIAM Director General Rajesh Menon told PTI.
IBAI votes out its president Sanjay Kedia, elects five new faces as directors
IBAI’s 15-member board of directors, have chosen Sumit Bohra as the new the new president of the association.
After voting out some existing directors who were seeking re-election, the brokers had elected five new faces as directors for three years,.
They are Sundaram Venkatavaradan of Abhivridhi Insurance Brokers. Rashmi Ravi Iyer of Global Insurance Brokers, Sandeep Dadia of Aditya Birla Insurance Brokers, Mohan Sriraman of Paavana Insurance Brokers, Surender Kumar Tonk of Advance Life Insurance Brokers
Gadkari suggests formation of state water grid in Maharashtra to overcome flood crisis
The floods create and trigger serious problems in different parts of the state and there is an urgent need to chalk out a plan to manage this natural disaster that becomes grave because of other man made factors,” a statement from the Minister’s office said.
India’s COVID-19 infection tally crosses 74 lakh with 62,212 new cases
There are 7,95,087 active cases of coronavirus infection in the country which comprises 10.70 per cent of the total caseload, while the recoveries have surged to 65,24,595, according to the data.
The COVID-19 case fatality rate due COVID-19 was recorded at 1.52 per cent.
According to the Indian Council of Medical Research (ICMR), a cumulative total of 9,32,54,017 samples have been tested up to October 16 with 9,99,090 samples being tested on Friday
India took host of measures to combat COVID-19 impact: Nirmala Sitharaman to World Bank
“Measures have been announced to provide relief to the business, bring about major reforms in the labour sector by simplifying, amalgamating and rationalising 44 central labour laws, provide effective social protection to the migrant workers through National Portability of ration cards,” she said, as per a statement issued by the finance ministry.
Indicators point to economic recovery, but recouping may be fragile: Report
The sharpest contraction was in the construction sector (-50.3 percent), followed by trade, hotels, transport, storage and communication (-47 percent) and manufacturing (-39.3 percent).
Haldiram’s crucial data stolen; hackers demand ₹7.50 lakh to release information
According to the FIR lodged at Sector 58 police station, the cyber attack took place on the intervening night of October 12 and 13 and the hackers may have stolen “entire or substantial data” of the company which runs several restaurants and outlets.
Dr Reddy’s gets DCGI nod to conduct Covid-19 vaccine phase 2/3 human trails
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, “We are pleased to collaborate with the Indian regulators and in addition to Indian clinical trial data, we will provide safety and immunogenicity study from the Russian phase 3 clinical trial.This data will further strengthen the clinical development of Sputnik V vaccine in India.”
India begins selecting people for priority coronavirus vaccines
The plan, which is still in the draft stage, aims to cover 23% of the population in the first phase. The final plan is likely to be ready by end October-November, the report said.
The selected individuals will be given an estimated 600 million doses.